Microflow Cytometry Prostate Cancer Diagnosis Machine Learning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for characterizing and analyzing extracellular vesicles (EVs) using microflow cytometry (µFCM) face challenges in handling large and complex data sets, which are crucial for diagnosing diseases like prostate cancer, as they generate millions of events per minute, requiring improved analysis tools for high-throughput and clinically meaningful results.
Innovation Solution
A method involving incubation of patient samples with biomarker-specific probes, followed by microflow cytometry to obtain signal intensities, processing with custom algorithms, and using machine learning to diagnose diseases like clinically significant prostate cancer, utilizing particle phenotype concentrations and optical properties for accurate diagnosis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If microflow cytometry is used to analyze EVs, then high-throughput characterization and quantification of particle size, concentration, and marker abundance are achieved, but large amounts of complex data are generated that complicate analysis
Solution Approach 1:
The patent introduces machine learning algorithms as an intermediary between the microflow cytometry data acquisition system and the diagnostic interpretation. These algorithms automatically process the large volumes of complex data generated by μFCM, identifying patterns and biomarkers without requiring manual analysis of millions of events. The machine learning component acts as a mediator that transforms raw high-throughput data into clinically actionable insights, resolving the contradiction between high productivity and analysis complexity.
2Ease of operation
If traditional cell-based flow cytometry analysis with bivariate scatter plots and user-defined regions of interest is used, then simple quantification is achieved, but the analysis is too simplistic for EVs that range in size and marker abundance
Solution Approach 1:
The patent transforms the analysis approach by changing from manual region-of-interest definition to machine learning-based automated parameter extraction. The system evaluates multiple optical properties simultaneously (including light scatter, fluorescence intensity, and pulse characteristics) rather than relying on simple bivariate plots. This parameter transformation enables precise characterization of size-variable EVs with diverse marker abundance while maintaining operational ease through automated processing.
Solution Approach 2:
The patent replaces the manual mechanical process of defining regions of interest on scatter plots with an automated machine learning system. Instead of users manually drawing gates and regions to quantify events, the machine learning algorithms automatically identify EV populations and extract quantitative features from the high-dimensional data space, providing both simplicity and precision simultaneously.
3Measurement precision
If EVs are characterized using electron microscopy, then highest resolution images are obtained, but high-throughput data acquisition is lacking and data analysis is time consuming and complicated
Solution Approach 1:
The patent replaces electron microscopy's imaging-based detection with optical-based microflow cytometry detection. Instead of capturing static high-resolution images that require time-consuming analysis, the system uses optical properties (light scatter, fluorescence) to rapidly characterize EVs in high-throughput mode. The machine learning component then extracts precise characterization data from these optical measurements, achieving both speed and accuracy without relying on image-based methods.
4Productivity
If nanoparticle tracking analysis or tunable resistive pulse sensing is used, then rapid enumeration and sizing are achieved, but characterization of EV markers is not ideal
Solution Approach 1:
The patent merges the rapid enumeration capability of nanoparticle tracking analysis with the marker characterization capability of flow cytometry. The microflow cytometry system simultaneously measures particle size (enabling rapid enumeration) and multiple optical markers (enabling precise characterization). The machine learning algorithms integrate these multiple measurement streams to provide both rapid sizing and accurate marker profiling in a single high-throughput assay, resolving the contradiction between speed and characterization quality.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enhances the accuracy of prostate cancer diagnosis by identifying key biomarkers and particle phenotypes, improving the prediction of clinically significant prostate cancer with a sensitivity of 89% and specificity of 49%, reducing unnecessary biopsies by half while maintaining high sensitivity.
Implementation Method 1
μFCM allows high-throughput characterization of the optical properties of particles, allowing quantification of particle size, concentration, and marker abundance
Data Source
Figure 1
Figure 2a~2d
Figure 3a~3e
AI summary
Disclosed are methods of diagnosing disease, such as clinically significant prostate cancer, in a patient. Also disclosed are methods for identifying a disease signature. The methods involve microflow (µFCM) cytometry to identify particle phenotypes and then using machine learning to determine whether the patient has the disease of interest or the particle phenotypes of a particle disease. The µFCM analysis workflow disclosed herein helps identify the most clinically useful information within µFCM data which may be overlooked by conventional gating analysis.